搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
9 小时
Sagimet Soars: FDA Breakthrough Therapy Designation And Lancet Review Validate Denifanstat
Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...
ENDPOINTS NEWS
9 小时
FDA won't take action against GLP-1 compounders as it rethinks tirzepatide shortage
The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...
12 小时
CDC’s Daskalakis talks bird flu
We spoke with Dr. Demetre Daskalakis, the director of the CDC’s National Center for Immunization and Respiratory Diseases, about the agency’s avian flu response.
Endocrinology Advisor
16 小时
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its decision to remove it.
Prescott eNews
21 小时
Pharmacy Leader Warns of Counterfeit Weight-Loss Drug Crisis – Inside Sources
Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈